作者: Xiao-Zhou Zou , Ting Liu , Zhi-Cheng Gong , Chang-Ping Hu , Zheng Zhang
DOI: 10.1016/J.EJPHAR.2016.12.003
关键词: microRNA 、 Cancer research 、 Pulmonary fibrosis 、 Signal transduction 、 Renal fibrosis 、 Epithelial–mesenchymal transition 、 Fibrosis 、 Immunology 、 Hepatic fibrosis 、 Biology 、 Cardiac fibrosis
摘要: MicroRNAs (miRNAs), a large family of small and highly conserved non-coding RNAs, regulate gene expression through translational repression or mRNA degradation. Aberrant miRNAs underlies spectrum diseases including organ fibrosis. Recent evidence suggests that contribute to fibrosis mediating epithelial-mesenchymal transition (EMT). Alleviation EMT has been proposed as promising strategy against fibrotic given the key role in impact specific ligands, receptors, signaling pathways, thus modulating consequently influencing This review summarizes current knowledge concerning how highlights roles miRNAs-regulated plays diverse pulmonary fibrosis, hepatic renal cardiac It is desirable more comprehensive understanding functions will facilitate development novel diagnostic therapeutic strategies for various debilitating